Search research articles
Contact Us
Filters
Showing results (61-70 of 145) with videos related to
Page
of 15
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
May 1, 1982
Management of primary germ cell tumors of the mediastinum
J S Economou, D L Trump, E C Holmes, et al.
Seminars in Urologic Oncology
|
May 20, 1999
Vitamin D in the prevention and treatment of prostate cancer
B R Konety, C S Johnson, D L Trump, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis
G Pirtskhalaishvili, G V Shurin, C Esche, et al.
Investigational New Drugs
|
January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer
R S Witte, P Hsieh, P Elson, et al.
The American Journal of Medicine
|
April 1, 1980
Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature
D L Trump, R B Mann, R Phelps, et al.
Urology
|
April 1, 1995
Renal cell carcinoma: considerations for nephron-sparing surgery
S E Lerner, H Tsai, R C Flanigan, et al.
Cancer
|
November 1, 1986
Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature
J L Grem, H I Robins, K S Wilson, et al.
Investigational New Drugs
|
May 1, 1993
5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology Group
B J Roth, P Elson, G W Sledge, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1982
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase
S M Lippman, G Mendelsohn, D L Trump, et al.
Urology
|
April 11, 2001
Androgen antagonists: Potential role in prostate cancer prevention
D L Trump, J A Waldstreicher, G Kolvenbag, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 145) with videos related to
Sort By:
Page
of 15
The Journal of Thoracic and Cardiovascular Surgery
|
May 1, 1982
Management of primary germ cell tumors of the mediastinum
J S Economou, D L Trump, E C Holmes, et al.
Seminars in Urologic Oncology
|
May 20, 1999
Vitamin D in the prevention and treatment of prostate cancer
B R Konety, C S Johnson, D L Trump, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis
G Pirtskhalaishvili, G V Shurin, C Esche, et al.
Investigational New Drugs
|
January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer
R S Witte, P Hsieh, P Elson, et al.
The American Journal of Medicine
|
April 1, 1980
Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature
D L Trump, R B Mann, R Phelps, et al.
Urology
|
April 1, 1995
Renal cell carcinoma: considerations for nephron-sparing surgery
S E Lerner, H Tsai, R C Flanigan, et al.
Cancer
|
November 1, 1986
Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature
J L Grem, H I Robins, K S Wilson, et al.
Investigational New Drugs
|
May 1, 1993
5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology Group
B J Roth, P Elson, G W Sledge, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1982
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase
S M Lippman, G Mendelsohn, D L Trump, et al.
Urology
|
April 11, 2001
Androgen antagonists: Potential role in prostate cancer prevention
D L Trump, J A Waldstreicher, G Kolvenbag, et al.
Page
of 15